Drug treatment of postmenopausal osteoporosis: What's new in 2006;Traitement médicamenteux de l'ostéoporose post-ménopausique: Actualisation 2006

Presse Medicale

Volumn 35, Issue 10 II, 2006, Pages 1529-1539

  Roux, Christian ^a   Briot, Karine ^a   Dumarcet, Nathalie ^b   Bourgoin, Michel ^c   Chapurlat, Roland ^d   Christin Maitre, Sophie ^e   Cortet, Bernard ^f   Costagliola, Dominique ^g   Diebolt, Vincent ^h   Lacoin, François ^c   Letombe, Brigitte ^h   Oberlin, Flavien ^h   Orcel, Philippe ⁱ   Ravaud, Philippe ^j   Seret, Patrick ^h   Thomas, Thierry ^g   Vogel, Jean Yves ^k   Barna, Alexandre ^l   Nouyrigat, Emmanuel ^b   Veyries, Marie Laure ^b   Yoldjian, Isabelle ^b   more..

^a Hôpital Cochin ^*  (France)

^b AFSSAPS   (France)

^c Cabinet Médical

^d EDOUARD HERRIOT HOSPITAL   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g INSERM   (France)

^h Cabinet Médical   (France)

ⁱ CENTRE VIGGO PETERSEN   (France)

^j BICHAT HOSPITAL   (France)

^k Ctr de Gerontologie des Hop Univ   (France)

^l HAS ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONATE TEVA; ALENDRONIC ACID; CALCIUM; ETIDRONIC ACID; FOSAVANCE; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; VITAMIN D;

BODY MASS; BONE DEFECT; BONE DENSITOMETRY; BONE DENSITY; BONE FRAGILITY; DRUG TOLERANCE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR; HUMAN; LIMB; LONG TERM CARE; MEDICAL DECISION MAKING; MENOPAUSE; NEUROMUSCULAR FUNCTION; OSTEOPENIA; PHYSICAL ACTIVITY; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK FACTOR; TOBACCO DEPENDENCE; TREATMENT DURATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 33749585232     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(06)74847-3     Document Type: Review

References (0)